Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB-Reference-Cited by-同舟云学术

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB

Published:2023-05 Issue:5 Volume:29 Page:
ISSN:1080-6040
Container-title:Emerging Infectious Diseases
language:
Short-container-title:Emerg. Infect. Dis.

Author:

Millard James,Rimmer Stephanie,Nimmo Camus,O’Donnell Max

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference10 articles.

1. World Health Organization. Rapid communication: key changes to the treatment of drug-resistant tuberculosis. Geneva: The Organization; 2022 [cited 2022 Oct 6]. https://www.who.int/publications/i/item/WHO-UCN-TB-2022-2

2. ZeNix Trial Team. Bedaquiline–pretomanid–linezolid regimens for drug-resistant tuberculosis.;Conradie;N Engl J Med,2022

3. A 24-week, all oral regimen for rifampicin-resistant tuberculosis.;Nyang’wa;N Engl J Med,2022

4. Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.;Nimmo;Lancet Microbe,2020

5. Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis.;Bloemberg;N Engl J Med,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysis;New Microbes and New Infections;2024-08

2. Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia;Emerging Infectious Diseases;2024-03

3. Emerging bedaquiline resistance: A threat to the global fight against drug-resistant tuberculosis;Journal of Biosafety and Biosecurity;2024-03

4. Multidrug-resistant tuberculosis in Iran: a multicenter study;Monaldi Archives for Chest Disease;2024-01-12

5. Frameshift Mutations in Rv0678 Preserve Bedaquiline Susceptibility in Mycobacterium Tuberculosis by Maintaining Protein Integrity;2024